Annals of Intensive Care (Jul 2019)

Serum biomarkers of delirium in the elderly: a narrative review

  • Katharina Toft,
  • Janna Tontsch,
  • Salim Abdelhamid,
  • Luzius Steiner,
  • Martin Siegemund,
  • Alexa Hollinger

DOI
https://doi.org/10.1186/s13613-019-0548-1
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Delirium after surgery and in the intensive care unit (ICU) remains a challenge for patients, families, and caregivers. Over the years, many promising biomarkers have been investigated as potential instruments for risk stratification of delirium. This review aimed to identify and assess the clinical usefulness of candidate serum biomarkers associated with hospital delirium in patients aged 60 years and older. We performed a time-unlimited review of publications indexed in PubMed, Cochrane, Embase, and MEDLINE databases until June 2019 that evaluated baseline and/or longitudinal biomarker measurements in patients suffering from delirium at some point during their hospital stay. A total of 32 studies were included in this review reporting information on 7610 patients. Of these 32 studies, twenty-four studies reported data from surgical patients including four studies in ICU cohorts, five studies reported data from medical patients (1026 patients), and three studies reported data from a mixed cohort (1086 patients), including one study in an ICU cohort. Findings confirm restricted clinical usefulness to predict or diagnose delirium due to limited evidence on which biomarkers can be used and limited availability due to non-routine use.